Европейски съюз - естонски - EMA (European Medicines Agency)

orphelia pharma sas - vigabatrin - spasms, infantile; epilepsies, partial - antiepileptics, - kigabeq on märgitud imikutel ja lastel alates 1 kuu vähem kui 7 aastased:ravi monotherapy infantiilse spasmid (lääne-sündroom). ravi kombinatsioonis teiste antiepileptilised ravimid patsientidel, kellel on vastupidav osaline epilepsia (fookuskaugus algusega krambid) koos või ilma sekundaarse teha üldistusi, et on koht, kus kõik muu sobiva ravimi kombinatsiooni on osutunud ebapiisavaks või ei ole talutav.

Европейски съюз - естонски - EMA (European Medicines Agency)

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - kopsuhaigus, krooniline obstruktiivne - formoterol ja glycopyrronium bromiid - bevespi aerosphere on näidustatud hooldus bronchodilator ravi, et leevendada sümptomeid täiskasvanud patsientidel, kellel on krooniline obstruktiivne kopsuhaigus (copd).

Европейски съюз - естонски - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib dietüülfumaraat - leukeemia, müeloidne, äge - antineoplastilised ained - xospata on näidustatud monotherapy raviks täiskasvanud patsientidel, kes on taastekkinud või tulekindlad ägeda müeloidse leukeemia (aml), mille flt3 mutatsioon.

Европейски съюз - естонски - EMA (European Medicines Agency)

bayer ag - larotrectinib sulfate - kõhu kasvajaid - antineoplastilised ained - vitrakvi nagu monotherapy on näidustatud ravi täiskasvanud ja pediaatriliste patsientide tahkete kasvajate, et kuvada neurotroofse retseptori türosiini kinase (ntrk) geen fusion,kes on haigus, mis on lokaalselt kaugelearenenud, metastaatilise või kui kirurgiline resektsioon tõenäoliselt põhjustada haigestumist, andwho on rahuldavat ravi valikud.

Европейски съюз - естонски - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ciclesonide - hingamiselundite muud ravimid hingamisteede obstruktiivsete haiguste, inhalants - hobused - eest leevendamine kliinilised tunnused on raske hobuste astma (varem tuntud korduvad hingamisteede obstruktsioon – (rao), suvel karjamaal seotud korduvate hingamisteede obstruktsioon – (spa-rao)).

Европейски съюз - естонски - EMA (European Medicines Agency)

pfizer europe ma eeig - glasdegib maleate - leukeemia, müeloidne, äge - antineoplastilised ained - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Европейски съюз - естонски - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Европейски съюз - естонски - EMA (European Medicines Agency)

astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastilised ained - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.

Европейски съюз - естонски - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Европейски съюз - естонски - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaktsiinid - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.